Articles published by Pliant Therapeutics, Inc.
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
Pliant Therapeutics to Participate in Upcoming Investor Events
August 28, 2024
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 07, 2024
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 06, 2024
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results
February 27, 2024
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg)
Pliant Therapeutics to Participate in Upcoming Investor Conferences
February 26, 2024
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
Pliant Therapeutics to Participate in Upcoming Investor Events
February 07, 2024
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 09, 2023
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
Pliant Therapeutics to Participate in Upcoming Investor Conferences
November 08, 2023
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
PLRX
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.